logo

Select Sidearea

Populate the sidearea with useful widgets. It’s simple to add images, categories, latest post, social media icon links, tag clouds, and more.

side-area-image-1
side-area-image-2
side-area-image-3
side-area-image-4
side-area-image-5
side-area-image-6
hello@youremail.com
+1234567890
mobile-logo

Psoriasis

First of 30 patients has been enrolled in a Phase 1b trial of patients suffering from Moderate Psoriasis 3Q2022

The study is being conducted in conjunction with Temple University in Philadelphia, PA. by Sylvia Hsu, MD. Chairman of the Department of Dermatology.

 

For information contact us at info@sfatherapeutics.com

 

Find more information regarding the study on the FDA Clinical Trial Posting Website:

 

SFA Therapeutics Psoriasis Study

Images represent results of open label limited exposure

Images are taken after 30 days.

Images are taken after 30 days.

Data is open label limited exposure

Images of patients taken after 30 days exposure

Data is open label limited exposure

A completely new approach to drug discovery and development.
(c) 2024

QUICK LINKS

CONTACT

  • 610 Old York Rd, Suite 400, Jenkintown, Pennsylvania 19046, United States
  • 267-584-1080
  • info@sfatherapeutics.com
slide-2-new
cell-signaling-slide_2_typo_corrected-01
01-master-switch-picture-scaled
covid-lung-image
Previous
Next